Keyphrases
N-methyl-D-aspartate Receptor (NMDAR)
100%
Urokinase
100%
Plasminogen Activator
100%
Airway Contractility
100%
Acetylcholine
75%
Contractility
75%
Plasminogen Activator inhibitor-1 (PAI-1)
50%
Reactive Airway Disease
50%
MK-801
25%
Epithelium
25%
Tissue Plasminogen Activator (t-PA)
25%
Specific mutation
25%
NMDAR Antagonist
25%
Tracheal Rings
25%
Smooth muscle Contraction
25%
Nitric Oxide Synthase Inhibitors
25%
L-NAME
25%
Urokinase-type Plasminogen Activator
25%
Airway Smooth muscle Contractility
25%
Human Aortic Smooth muscle Cells (HASMCs)
25%
Vascular Tone
25%
Docking Site
25%
Hexapeptide
25%
Activator Type
25%
Docking Domain
25%
Medicine and Dentistry
Muscle Contractility
100%
N Methyl-D-Aspartate Receptor
100%
Plasminogen Activator
100%
N-Methyl-D-Aspartic Acid
100%
Urokinase
83%
Acetylcholine
50%
Respiratory Disease
33%
Plasminogen Activator Inhibitor-1
33%
Receptor
16%
Tissue Plasminogen Activator
16%
Smooth Muscle Contractility
16%
Nitric Oxide Synthase Inhibitor
16%
Airway Smooth Muscle
16%
Blood Vessel Tone
16%
Smooth Muscle Contraction
16%
Airway Smooth Muscle Cell
16%
Hexapeptide
16%
Pharmacology, Toxicology and Pharmaceutical Science
Receptor
100%
N Methyl Dextro Aspartic Acid
100%
Aspartic Acid
100%
Plasminogen Activator
100%
Urokinase
100%
Acetylcholine
60%
Plasminogen Activator Inhibitor 1
40%
Respiratory Tract Disease
40%
Tissue Plasminogen Activator
20%
N Methyl Dextro Aspartic Acid Receptor
20%
Nitric Oxide Synthase Inhibitor
20%
Hexapeptide
20%